Catalyst Wire Dossier Catalyst Wire Dossier

Zovaglutide (ZT002 Injection)

Zovaglutide · Beijing QL Biopharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zovaglutide (ZT002 Injection), covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants [Phase 1]

See pricing